GlassScriptPhysician profile
Binit P Shah
NPI 1578726592
$27,374.00
in general payments reported to CMS, 2019-2025
34 companies · $3,266 in 2025
The $3,266 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,895 · 2020: $2,311 · 2021: $8,932 · 2022: $2,471 · 2023: $1,925 · 2024: $4,574 · 2025: $3,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,140 · Travel and Lodging: $1,995 · Consulting Fee: $615 · Education: $15.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,139.90 |
| Travel and Lodging | $1,995.30 |
| Consulting Fee | $615.00 |
| Education | $15.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $9,297.67 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Medtronic, INC. | $4,965.30 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Activos 10 Bone Cement |
| Vertiflex, INC. | $2,600.42 | 2019 | |
| Saluda Medical Americas, INC. | $2,445.77 | 2023-2024 | Evoke, Evoke Scs |
| Medtronic USA, INC. | $1,541.45 | 2019-2020 | |
| Vertos Medical, INC. | $1,263.26 | 2020-2024 | Mild Device Kit |
| Curonix LLC | $1,215.19 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $1,101.01 | 2021-2025 | Reactiv8 |
| Painteq LLC | $775.41 | 2023-2025 | Painteq |
| Biotronik Nro, INC. | $410.72 | 2025 | Prospera |
| Spr Therapeutics, INC | $283.26 | 2019-2023 | Sprint Pns System |
| Abbott Laboratories | $209.92 | 2019-2022 | |
| Relievant Medsystems, INC. | $165.26 | 2021-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $162.22 | 2022-2025 | Belbuca |
| Siemens Medical Solutions USA, INC. | $139.35 | 2024 | Cios Select |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $131.51 | 2019-2020 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Nalu Medical, INC. | $84.50 | 2021-2022 | |
| Pfizer INC. | $82.82 | 2019-2020 | |
| Amgen INC. | $63.86 | 2019-2021 | |
| Grt US Holding, INC. | $57.51 | 2022 | |
| Nevro Corp. | $45.27 | 2019 | |
| Lilly USA, LLC | $43.57 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.51 | 2020 | |
| Novartis Pharmaceuticals Corporation | $33.68 | 2021 | |
| Abbvie INC. | $29.13 | 2021 | |
| Upsher-Smith Laboratories LLC | $18.53 | 2020 | |
| Spinal Simplicity, LLC | $15.68 | 2022 | |
| Almatica Pharma LLC | $13.38 | 2021 | |
| Forte Bio-Pharma LLC | $12.84 | 2021 | |
| Assertio Therapeutics, INC. | $12.29 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.01 | 2019 | |
| Biodelivery Sciences International, INC. | $11.20 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.